Bal Pharma

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue73.4275.0573.4082.7766.38
Expenses72.7073.5272.6579.9666.05
EBITDA6.857.838.448.826.90
EBIT4.435.705.766.754.37
Profit Before Tax0.721.520.742.820.32
Net Profit0.361.200.695.610.32
Financial Ratios
Operating Profit Margin9.37%10.47%11.59%10.79%10.50%
Net Profit Margin0.49%1.61%0.95%6.86%0.49%
Earning Per Share (Diluted)0.230.760.733.510.20
Dividends Per Share0.000.000.000.000.00